🟢 Health ETF (ARKG) is trading 5% up amid recent biotech and healthcare outperformance

ARKG is trading at $50.70, up 4.99%, amid healthcare and biotech strength.

• Healthcare and biotech recently outperformed the broader market; pharma and biotech gained close to 5% over the past week.
• Pfizer raised its 2026 profit forecast on strong Eliquis demand, a positive sector signal, but is not identified as a major ARKG holding.
• uniQure’s FDA priority review drew gene-therapy attention, but it is not a reported major ARKG holding or established as the ETF’s main driver.